Also known as: Altace; Tritace; Ramace
Ramipril is an ACE inhibitor widely used for the treatment of hypertension, heart failure, and to reduce the risk of myocardial infarction, stroke, and cardiovascular death. Mediocon Inc manufactures GMP-compliant Ramipril at its Aurangabad facility to international pharmacopoeial standards.
| Parameter | Specification |
|---|---|
| CAS Number | 87333-19-5 |
| Molecular Formula | C₂₃H₃₂N₂O₅ |
| Molecular Weight | 416.51 g/mol |
| Grade | IP / BP / EP / USP |
| Category | ACE Inhibitor / Antihypertensive |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | RMP/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Ramipril — CAS 87333-19-5 (CAS 87333-19-5) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Ramipril — CAS 87333-19-5 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance